Aryzta AG
OTC:ARZTY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aryzta AG
OTC:ARZTY
|
CH |
|
Superior Group of Companies Inc
NASDAQ:SGC
|
US |
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
TW |
|
Unibail-Rodamco-Westfield SE
OTC:URMCY
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ARZTY's stock price target?
Price Target
9.13
USD
According to Wall Street analysts, the average 1-year price target for
ARZTY is 9.13 USD with a low forecast of 5.17 USD and a high forecast of 12.36 USD.
What is the Revenue forecast for Aryzta AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Aryzta AG?
Projected CAGR
-12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 3 years is -12%.
What is the Operating Income forecast for Aryzta AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 5%.
What is the Pre-Tax Income forecast for Aryzta AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Aryzta AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 8%.